Temozolomide and MGMT forever? - Wikidata - awgldk - TriplyDB

Temozolomide and MGMT forever?

Temozolomide and MGMT forever?

http://www.wikidata.org/entity/Q42426015

about

Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature.

P2860

Q37955091-63CA2AA7-DFC6-4948-AB18-2FCCB7BEABAA

P2860

Temozolomide and MGMT forever?

http://www.wikidata.org/entity/Q42426015

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Temozolomide and MGMT forever?

@en

Temozolomide and MGMT forever?

@nl

type

label

Temozolomide and MGMT forever?

@en

Temozolomide and MGMT forever?

@nl

prefLabel

Temozolomide and MGMT forever?

@en

Temozolomide and MGMT forever?

@nl

P1433

Q42426015-3236E11B-6BFA-4458-8B6E-AFB8DD83E8D6

P1476

Q42426015-D21FC733-26D4-458C-9A26-BC555B903A63

P2860

Q42426015-4A3D9A02-8F18-4DED-AF85-04399E34420F

Q42426015-5310B9EC-D713-4766-B66C-BAC5B291B2BA

Q42426015-5B4911B8-274E-4B84-8640-2FD850345C4A

Q42426015-627B71FA-6DBA-4512-956F-3EBF505027D6

Q42426015-6292038C-BE7B-44CB-A42C-6F2D6FBFAD28

Q42426015-78FD49B9-DAC9-48D8-AE8B-89361660F534

Q42426015-988737B7-D5F1-4E38-8401-452C97C280E2

Q42426015-BEEF18B4-14EF-4F81-8F74-D070463CDE2B

Q42426015-C8894964-5A2C-4073-97B2-1F9DD5A316C3

Q42426015-E6AD5124-A7FD-4E9F-AB3C-AE38288705B5

P304

Q42426015-BB421242-98F8-405E-AD81-035D585943EB

P31

Q42426015-3912E7FD-AE56-4074-9C7B-44EAD117DF2B

Q42426015-89a1f32c-c071-4446-aaad-c88bf4513cf4

P356

Q42426015-DB446A45-B073-4FEE-BAE1-B6D0DB64597B

P433

Q42426015-1E6DE8A5-4BE6-4250-8BCD-E73E146B031F

P478

Q42426015-ACB56BC9-5652-49EA-A1A8-523B72950667

P50

Q42426015-3E8BB0B9-DC92-4239-977B-C2EC933D106A

P577

Q42426015-15094D44-AE3F-4A0F-A1F8-35B783B37087

P5875

Q42426015-A7AC822C-960D-483D-812D-AE2063BEC59F

P698

Q42426015-6FD19803-A055-4F83-A290-FC8B936ED420

P932

Q42426015-6E1B8714-D515-454D-A3D5-7B0BBCCAE29A

P356

P1433

P1476

Temozolomide and MGMT forever?

@en

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.

Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma.

O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications.

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO).

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

Rechallenge with temozolomide in patients with recurrent gliomas.

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the "rescue" approach.

Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma.

P304

219-220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOQ016

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41486446

http://www.w3.org/2001/XMLSchema#string

P698

20167809

http://www.w3.org/2001/XMLSchema#string

P932

2940592

http://www.w3.org/2001/XMLSchema#string